The search for an effective induction agent with analgesic properties led to the study of the cyclohexylamines by the Parke-Davis Company in the 1950s. Two compounds initially appeared promising-1-(1-phenylcyclohexyl) piperidine hydrochloride (Sernyl or CI395) and N-ethyl-1-phenylcyclohexylamine hydrochloride (CI 400).
Sernyl (phencyclidine) was tested by Greifenstein and colleagues in Detroit and they reported their findings in 1958. After preliminary studies on seven healthy individuals, the drug was used on 64 patients for a wide variety of surgical procedures. The authors concluded that the drug deserved further evaluation although the results were quite disturbing. Thirteen of the patients had unsatisfactory anaesthesia. Five of these suffered severe agitation bordering on mania and three others had definite convulsive movements. Postoperatively there were similar problems with 10 of the patients displaying manic or violent behaviour in the recovery room. These reactions were of variable duration with one woman taking 15 hours to become orientated.
There were some positive findings, namely potent analgesia and amnesia and preservation of airway reflexes. No patients had any memory of pain or the operative procedure. A mild increase in blood pressure was noted along with an increase in respiratory rate. Salivation was excessive in all cases. It was hoped that CI 400 would prove to be equally efficacious without the hallucinations.
Collins and his colleagues reported on their clinical observations of CI 400 in 29 patients. Overall they found the results to be fairly unsatisfactory. The drug produced analgesia without complete anaesthesia in about sixty per cent of patients but many were very agitated. Many had blurred vision and disorientation for up to four hours postoperatively and over half described unusual loss of contact and loss of sensation. Once again the blood pressure and respiratory rate were raised.
The patients described an unpleasant feeling of generalized numbness, "going away" and "drifting". They experienced frequent hallucinations which were often unpleasant or embarrassing and they preferred not to recount them later. "The outstanding effect of the drug was the development of a state of catatonia. First, this condition was manifested by flat facies and a complete loss of expression. The mouth would open while the eyes became fixed and staring. No response to waving in the front of the eyes could be elicited, and objects were not sighted. The report concludes that "cyclohexylamines produce sensory blockade and mental dissociation, and catatonia is the prominent manifestation."
Research continued on this group of drugs, largely with Sernyl, and by 1963 Parke-Davis was recommending its use only for the elderly and children under six. "the very old and the very young not only tolerate phencyclidine anaesthesia well, but derive the greatest advantage from its unique properties, namely the absence of respiratory or cardiovascular depression and the safety of using the drug shortly after a meal."
In 1965 Guenter Corssen and Edward Domino conducted trials on derivative CI-581, or ketamine. They anaesthetized 130 patients, most with a single intravenous injection of 0.5-1.0 mg/lb. Seven patients required repeat injections and infants were given intramuscular ketamine. They noted that the anaesthesia produced was very different to that with other classes of induction agents "CI-581 appears to produce a state resembling cataplexy". They also recorded that patients became dissociated and "felt as though they were in outer space, or had no arms and legs". They recommended that "the state induced by CI-581 be called dissociative anaesthesia"-a term which was rapidly adopted. They concluded that the drug had particular advantages in children and required further evaluation in adults.
By 1968, ketamine was proving an effective anaesthetic and analgesic agent. Airway reflexes were preserved and there were no hypotensive effects. There was virtually no postoperative nausea and vomiting and it had a wide margin of safety. The principal problem remained that of vivid dreams and hallucinations during emergence. It was soon realized that these reactions were much more profound if the patients were disturbed during recovery and patients were usually left alone until fully awake. The dreams and hallucinations were not observed in young children and many researchers recommended that it be used mainly in this age group.
Ketamine was released in the U.K. in the early 1970s but most anaesthetists found it unacceptable as the sole agent in adults. Benzodiazepines were used to modify the hallucinations but this removed some of the most desirable features of ketamine, namely the preservation of airway reflexes and blood pressure. Ketamine was found to be useful in field anaesthesia (e.g. train crashes and war conditions) and was used for children having repeat procedures such as burns dressings or radiotherapy. Barbara Collier, who conducted one of the early British trials, raised an interesting ethical problem: "It is a matter of opinion whether or not a chemically induced transcendental experience should be available to anyone who desires it, but to induce such a state when it is not requested by the patient is a different ethical problem." One of her patients who had previously experienced both marihuana and LSD found the experience unpleasant but similar to the other drugs. He described the ward becoming a deep red colour and he feared he would float through a huge crevasse in the ceiling which was in fact a repaired crack. His advice was that the drug "should be kept away from youngsters".
Sadly his comment was prescient and ketamine is now a popular street drug. It is still used in anaesthesia, particularly in very low doses as an analgesic, and it is widely used in veterinary anaesthesia. Stolen veterinary supplies form the basis of the street supplies of the drug which is marketed as "Vitamin K, Special K or simply, K.
